Brief: Cumberland Enters Into Amendment To Expand Capital Available On Bank Line Of Credit To $20 Million
03/01/2022 14:25
Jan 3 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS INC - ON DECEMBER 31, ENTERED
INTO
AN AMENDMENT TO EXPAND CAPITAL AVAILABLE ON ITS BANK LINE OF
CREDIT TO $20 MILLION
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM